Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Antimicrobial Chemotherapy|February 6, 2015
Steady-state pharmacokinetics of rilpivirine under different meal conditions in HIV-1-infected Ugandan adultsMohammed Lamorde, Stephen Walimbwa, Pauline Byakika-Kibwika, et al.
British Journal of Clinical Pharmacology|October 10, 2014
Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implicationsRichard M Hoglund, Pauline Byakika-Kibwika, Mohammed Lamorde, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 2008
Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individualsLaura Dickinson, Marta Boffito, David J Back, et al.
AIDS Research and Treatment|March 29, 2012
Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan AdultsMohammed Lamorde, Pauline Byakika-Kibwika, William S Tamale, et al.
The Journal of Antimicrobial Chemotherapy|November 5, 2010
Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicinMohammed Lamorde, Pauline Byakika-Kibwika, Violet Okaba-Kayom, et al.
Chemotherapy Research and Practice|February 8, 2012
Cardiac Conduction Safety during Coadministration of Artemether-Lumefantrine and Lopinavir/Ritonavir in HIV-Infected Ugandan AdultsPauline Byakika-Kibwika, Mohammed Lamorde, Peter Lwabi, et al.
Ticks and Tick-Borne Diseases|March 14, 2017
Splenic dysfunction from celiac disease resulting in severe babesiosisSarah O'Connell, Craig Lyons, Moustafa Abdou, et al.
The Journal of Antimicrobial Chemotherapy|July 22, 2008
Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adultsPauline Byakika-Kibwika, Mohammed Lamorde, Francis Kalemeera, et al.
Pageof 5